| Name |
Wellbutrin XR 300 mg tablete s prilagođenim oslobađanjem |
| Marketing Authorisation Number |
HR-H-345088727 |
| Active Substance |
bupropionklorid |
| Composition |
jedna tableta sadrži 300 mg bupropionklorida |
| Pharmaceutical Form |
tableta s prilagođenim oslobađanjem |
| Manufacturer |
Glaxo Wellcome S.A., Aranda de Duero, Burgos, Španjolska |
| Marketing Authorisation Holder |
GlaxoSmithKline Trading Services Limited, 12 Riverwalk, Citywest Business Campus, Dublin 24, Irska |
| Marketing Authorisation Date |
20.08.2021 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/17-02/372 |
| Registration Number |
381-12-01/70-21-22 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
ponovljivi recept
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
N06AX12 |
| Marketing status |
stavljeno u promet |
| Shortage status |
nema nestašice |
| SmPC |
download |
| PL |
download |
